News + Filings Transactions Holdings
All 13F 13D/G Other
|
Growth Equity Opportunities V, LLC
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/12/2023 |
SC 13D/A
| Growth Equity Opportunities V, LLC reports a 10% stake in Regulus Therapeutics Inc. |
03/09/2023 |
SC 13D/A
| Growth Equity Opportunities V, LLC has filed a Schedule 13D for MEI Pharma, Inc. |
07/22/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
06/17/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/09/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
11/19/2021 |
SC 13D/A
| Growth Equity Opportunities V, LLC has filed a Schedule 13D for Trillium Therapeutics Inc. |
08/31/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/07/2020 |
4
| Growth Equity Opportunities V, LLC (10% Owner) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Bought 4,398,602 shares
@ $0.622, valued at
$2.7M
Bought 5,239,254 warrants
@ $0.7464, valued at
$3.9M
Bought 258,707 options to buy
@ $6.22, valued at
$1.6M
|
|
03/12/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/13/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
02/04/2020 |
SC 13D/A
| Growth Equity Opportunities V, LLC reports a 8.7% stake in Trillium Therapeutics Inc. |
12/30/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/15/2019 |
SC 13D/A
| Growth Equity Opportunities V, LLC reports a 10% stake in Regulus Therapeutics Inc. |
05/09/2019 |
4
| Growth Equity Opportunities V, LLC (10% Owner) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Bought 1,136,704 shares
@ $1.08, valued at
$1.2M
Bought 3,703,704 warrants
@ $1.08, valued at
$4M
Bought 256,700 options to buy
@ $10.8, valued at
$2.8M
|
|
03/04/2019 |
SC 13D/A
| Growth Equity Opportunities V, LLC reports a 10% stake in Trillium Therapeutics Inc. |
05/23/2018 |
SC 13D
| Growth Equity Opportunities V, LLC reports a 10% stake in MEI Pharma, Inc. |
02/20/2018 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
12/05/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
08/02/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
07/31/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|